GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
GE HealthCare Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)
Close on Oct 19, 2026
- Market cap
- $31.67B
- P/E (TTM)
- 16.0
- Dividend yield
- 0.20%
GE HealthCare Technologies Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PDx | $3.15B | $3.04B | $2.90B | $2.76B | $2.63B | $2.54B | $2.51B | $2.45B | $2.42B | $2.35B | $2.31B | $2.19B | 14.8% | +19.8% |
| PCS | $2.93B | $3.04B | $3.09B | $3.09B | $3.14B | $3.13B | $3.13B | $3.13B | $3.11B | $3.11B | $3.14B | $3.10B | 13.8% | -6.5% |
| Ultrasound | – | – | – | – | – | – | – | – | $3.41B | $3.42B | $3.46B | $3.47B | – | – |
| Imaging | – | $9.40B | $9.25B | $9.09B | $8.97B | $8.93B | $8.86B | $8.85B | $8.86B | $9.31B | $8.94B | $8.47B | – | – |
| AVS | – | $5.46B | $5.35B | $5.27B | $5.18B | $5.14B | $5.13B | $5.07B | $5.07B | – | $5.09B | – | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $14.04B | $13.89B | $13.66B | $13.38B | $13.20B | $13.15B | $13.08B | $13.05B | $13.04B | $13.04B | $13.13B | $12.87B | 66.0% | +6.4% |
| Service | $7.23B | $7.09B | $6.96B | $6.87B | $6.76B | $6.65B | $6.60B | $6.51B | $6.48B | $6.45B | $6.43B | $6.41B | 34.0% | +6.8% |
By region
From the segment and revenue-disaggregation notes of GE HealthCare Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.